Potential Clindamycin Resistance in Clindamycin-Susceptible, Erythromycin-Resistant Staphylococcus aureus: Report of a Clinical Failure
AUTOR(ES)
Levin, Todd P.
FONTE
American Society for Microbiology
RESUMO
The erm gene product confers clindamycin resistance on Staphylococcus aureus. We report a clindamycin clinical failure where resistance developed on therapy in a D-test-positive strain. D tests of 91 clindamycin-susceptible, erythromycin-resistant S. aureus isolates showed that 68% of methicillin-susceptible and 12.3% of methicillin-resistant S. aureus strains were D-test positive.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=549252Documentos Relacionados
- Emergence of Erythromycin-Resistant, Clindamycin-Susceptible Streptococcus pyogenes Isolates in Madrid, Spain
- Altered Methylation of Ribosomal RNA in an Erythromycin-Resistant Strain of Staphylococcus aureus
- Differentiation of Resistance Phenotypes among Erythromycin-Resistant Pneumococci
- Prevalence of erm gene classes in erythromycin-resistant Staphylococcus aureus strains isolated between 1959 and 1988.
- Erythromycin-resistant Campylobacter infections in Thailand.